Tudor Investment Corp’s Ocular Therapeutix OCUL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.2M	Buy	614,378 +119,586	+24%	+$1.14M	0.03%	1138
2025 Q4	$6.01M	Buy	494,792 +332,893	+206%	+$4.04M	0.03%	1041
2025 Q3	$1.89M	Buy	+161,899	New	+$1.94M	0.01%	1842
2025 Q2	–	Sell	-79,648	Closed	-$584K	–	3864
2025 Q1	$584K	Buy	+79,648	New	+$612K	0.01%	2185
2024 Q2	–	Sell	-74,531	Closed	-$678K	–	2751
2024 Q1	$678K	Sell	74,531 -64,200	-46%	-$456K	0.01%	1517
2023 Q4	$619K	Sell	138,731 -35,436	-20%	-$105K	0.01%	1679
2023 Q3	$547K	Sell	174,167 -26,676	-13%	-$109K	0.01%	1632
2023 Q2	$1.04M	Buy	200,843 +132,459	+194%	+$788K	0.02%	1299
2023 Q1	$360K	Sell	68,384 -30,954	-31%	-$147K	0.01%	1809
2022 Q4	$279K	Buy	99,338 +37,563	+61%	+$124K	0.01%	1950
2022 Q3	$256K	Buy	61,775 +10,736	+21%	+$54.1K	0.01%	1895
2022 Q2	$205K	Buy	+51,039	New	+$193K	0.01%	1809
2022 Q1	–	Sell	-40,987	Closed	-$286K	–	2563
2021 Q4	$286K	Sell	40,987 -53,725	-57%	-$417K	0.01%	1881
2021 Q3	$947K	Buy	+94,712	New	+$1.06M	0.02%	1195
2016 Q1	–	Sell	-12,700	Closed	-$119K	–	1932
2015 Q4	$119K	Buy	+12,700	New	+$137K	﹤0.01%	1513
2015 Q3	–	Sell	-17,663	Closed	-$371K	–	1693
2015 Q2	$371K	Buy	+17,663	New	+$438K	0.01%	974